Antipsychotics Flashcards
Plays key role which argues that psychosis can be explained by changes of these neurotransmitter in brain
Dopamine
Pathway hyperactive in schizophrenia
Mediates positive symptoms such as delusions and hallucinations
Mesolimbic
Pathway underactive in schizophrenia
Mediates negative psychotic symptoms such as loss of motivation and social withdrawal
Mesocortical
Part of EPS
Controls motor function and movement
Deficiency of dopamine in this pathway leads to dystonia and parkinsonian symptoms
Excess of dopamine in this pathway leads to tics and dyskinesia
Nigrostriatal
Pathway that controls prolactin secretion
Dopamine in this pathway inhibits prolactin release
Tuberoinfundibular
5 primary types of dopamine receptors
Highest density of receptors involved in psychotic disorder
Most clinically relevant
D1-D5
D1 and D2
D2 target of antipsychotics
Blocks D2 receptors in all areas of the brain leading to
reduction of positive symptoms (delusion, hallucination) worsening of negative symptoms (diminished energy, social disengagement) EPS disorders (tardive dyskinesia, tremors) increased prolactin (galactorrhea, gynecomastia, sexual dysfunction)
First generation typical antipsychotics
High potency first generation anti psychotics
Produce stronger antipsychotic effect at low doses but more EPS and rare increase in prolactin
Haloperidol
Fluphenazine
Prochlorperazine
Trifluoperazine
Low potency first gen antipsychotic
Do not bind to D2 receptors as tightly
Results in variety of side effects by blockade of alpha receptor (OH)
Blockade of muscarinic receptors (dry mouth, blurred vision, difficulty of urination)
Blockade of H1 histamine receptor (sedation, weight gain)
Chlorpromazine
Blocks both D2 and 5HT2A receptors
Significantly lowers incidence of EPS
Decreases negative symptoms
Also binds to histamine, alpha adrenergic and muscarinic receptors
2nd generation Atypical anti-psychotics
2nd gen Atypical antipsychotics
Clozapine Aripiprazole Lurasidone Olanzapine Quietiapine Risperidone Ziprasid
Strong affinity for 5HT2C
Causes metabolic side effects
Weight gain
Hyperglycemia
Hyperlipidemia
Clozapine
Olanzapine
Strong affinity for H1 receptors
Cause sedation
weight gain
Clozapine
Olanzapine
Quietiapine
Strong affinity for a1 adrenergic receptor
Cause OH
Clozapine
Risperidone
Strongest affinity for D2 receptor
Atypical antipsychotic with Highest potential to cause EPS and hyperprolactinemia
Risperidone